<DOC>
	<DOCNO>NCT02093468</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy MST-188 subject receive catheter-directed rt-PA acute lower limb ischemia evaluate whether treatment MST-188 result rapid thrombolysis occlusion rapid tissue perfusion effect blood vessel .</brief_summary>
	<brief_title>Evaluation MST-188 Acute Lower Limb Ischemia</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>Age â‰¥30 &lt; 80 Symptoms consistent ALI target lower limb classify Rutherford Category IIa IIb Subject hospitalize process hospitalization treatment ALI Angiographic confirmation thrombotic low limb arterial occlusion Prosthetic bypass graft occlusion within 1 month implantation autogenous graft occlusion within 6 month placement Treatment thrombolytic agent within last 48 hour Subject 's laboratory result indicate inadequate organ function NYHA Class IV congestive heart failure Prior major amputation target limb Other complication contraindication receive rtPA , anticoagulant , contrast medium</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Acute limb ischemia</keyword>
	<keyword>ALI</keyword>
	<keyword>Acute low extremity arterial occlusion</keyword>
</DOC>